Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
Autor (es)
De La Piedra, Concepción; Alcaraz, A.; Bellmunt, Joaquim; Meseguer, Cristina; Gómez Caamaño, Antonio; Ribal, María José; Vázquez, Fernando Javier; Anido, Urbano; Samper, Pilar María; Esteban, Emilio; Álvarez-Ossorio, Jose Luis; Lara, Pedro Carlos; San José, L. A.; Contreras, José Antonio Viedma; Del Alba, Aránzazu González; González-Gragera, B.; Tabernero, Ángel J.; González Enguita, María del Carmen; Fernández, Jesús María; García-Escudero, Antonio; Gómez-Veiga, Francisco J.; Méndez, Míriam J.; Segarra, José; Virizuela, Juan Antonio; Carles, Joan; Lassa, A.; Calderero, Verónica; Constela, Manuel; Delgado, Diego Hernán; Mañas, Ana; Murias, Adolfo; Reynés, Gaspar; Rodríguez, Begoña I.; Rubio, Gustavo; Sánchez, Ernesto Sánchez; Unda, Miguel; Solsona, Eduardo; Martínez Javaloyas, J. M.; Comet-Batlle, Josep; Quicios, C.; Martín-Fernández, Marta; Mahillo, Ignacio; Moróte, Juan MoróteEntidad
UAM. Departamento de CirugíaEditor
Nature Publishing GroupFecha de edición
2013-06-25Cita
10.1038/bjc.2013.270
British Journal of Cancer 108.12 (2013): 2565–2572
ISSN
0007-0920 (print); 1532-1827 (online)DOI
10.1038/bjc.2013.270Financiado por
This study was supported by Novartis Oncology SpainVersión del editor
http://dx.doi.org/10.1038/bjc.2013.270Materias
Prostate cancer; Bone metastases; Overall survival; Disease progression; Skeletal-related events; MedicinaDerechos
© 2013 Cancer Research UK. All rights reserved 0007 – 0920/13Resumen
Owing to the limited validity of clinical data on the treatment of prostate cancer (PCa) and bone metastases,
biochemical markers are a promising tool for predicting survival, disease progression and skeletal-related events (SREs) in these
patients. The aim of this study was to evaluate the predictive capacity of biochemical markers of bone turnover for mortality risk,
disease progression and SREs in patients with PCa and bone metastases undergoing treatment with zoledronic acid (ZA).
Methods: This was an observational, prospective and multicenter study in which ninety-eight patients were included. Patients
were treated with ZA (4mg every 4 weeks for 18 months). Data were collected at baseline and 3, 6, 9, 12, 15 and 18 months after
the beginning of treatment. Serum levels of bone alkaline phosphtase (BALP), aminoterminal propeptide of procollagen type I
(P1NP) and beta-isomer of carboxiterminal telopeptide of collagen I (b-CTX) were analysed at all points in the study. Data on
disease progression, SREs development and survival were recorded.
Results: Cox regression models with clinical data and bone markers showed that the levels of the three markers studied were
predictive of survival time, with b-CTX being especially powerful, in which a lack of normalisation in visit 1 (3 months after the
beginning of treatment) showed a 6.3-times more risk for death than in normalised patients. Levels of these markers were also
predictive for SREs, although in this case BALP and P1NP proved to be better predictors. We did not find any relationship
between bone markers and disease progression.
Conclusion: In patients with PCa and bone metastases treated with ZA, b-CTX and P1NP can be considered suitable predictors for
mortality risk, while BALP and P1NP are appropriate for SREs. The levels of these biomarkers 3 months after the beginning of
treatment are especially important
Lista de ficheros
Google Scholar:De La Piedra, Concepción
-
Alcaraz, A.
-
Bellmunt, Joaquim
-
Meseguer, Cristina
-
Gómez Caamaño, Antonio
-
Ribal, María José
-
Vázquez, Fernando Javier
-
Anido, Urbano
-
Samper, Pilar María
-
Esteban, Emilio
-
Álvarez-Ossorio, Jose Luis
-
Lara, Pedro Carlos
-
San José, L. A.
-
Contreras, José Antonio Viedma
-
Del Alba, Aránzazu González
-
González-Gragera, B.
-
Tabernero, Ángel J.
-
González Enguita, María del Carmen
-
Fernández, Jesús María
-
García-Escudero, Antonio
-
Gómez-Veiga, Francisco J.
-
Méndez, Míriam J.
-
Segarra, José
-
Virizuela, Juan Antonio
-
Carles, Joan
-
Lassa, A.
-
Calderero, Verónica
-
Constela, Manuel
-
Delgado, Diego Hernán
-
Mañas, Ana
-
Murias, Adolfo
-
Reynés, Gaspar
-
Rodríguez, Begoña I.
-
Rubio, Gustavo
-
Sánchez, Ernesto Sánchez
-
Unda, Miguel
-
Solsona, Eduardo
-
Martínez Javaloyas, J. M.
-
Comet-Batlle, Josep
-
Quicios, C.
-
Martín-Fernández, Marta
-
Mahillo, Ignacio
-
Moróte, Juan Moróte
Lista de colecciones del ítem
Registros relacionados
Mostrando ítems relacionados por título, autor, creador y materia.
-
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
Alcaraz, A.; González-López, Raquel; Morote, J.; De La Piedra, Concepción; Meseguer, Cristina; Esteban, Emilio; Climent, Miguel Ángel; González-Gragera, B.; Álvarez-Ossorio, Jose Luis; Chirivella, Isabel; Mellado, Begoña; Lara, Pedro Carlos; Vázquez, Fernando Javier; Contreras Viedma, José Antonio; Carles, Joan; Murias, Adolfo; Calderero, Verónica; Comet-Batlle, Josep; González Del Alba, Aránzazu; León Mateos, Luis A.; Mañas, Ana; Segarra, José; Lassa, A.; González Enguita, María del Carmen; Méndez, Míriam J.; Samper, Pilar María; Unda, Miguel; Mahillo, Ignacio; Bellmunt, Joaquim; Alcaraz, A.; González-López, Raquel; Morote, J.; De La Piedra, Concepción; Meseguer, Cristina; Esteban, Emilio; Climent, Miguel Ángel; González-Gragera, B.; Álvarez-Ossorio, Jose Luis; Chirivella, Isabel; Mellado, Begoña; Lara, Pedro Carlos; Vázquez, Fernando Javier; Contreras, José Antonio Viedma; Carles, Joan; Murias, Adolfo; Calderero, Verónica; Comet-Batlle, Josep; González Del Alba, Aránzazu; León Mateos, Luis A.; Mañas, Ana; Segarra, José; Lassa, A.; González Enguita, María del Carmen; Méndez, Míriam J.; Samper, Pilar María; Unda, Miguel; Mahillo, Ignacio; Bellmunt, Joaquim
2013-07-09 -
Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results
Alonso-Molero, Jessica; Molina, Antonio J.; Jiménez-Moleón, José Juan; Pérez-Gómez , Beatriz; Martín, Vicente; Moreno, Víctor; Amiano, Pilar; Ardanaz, Eva; Sanjose, Silvia; Salcedo, Inmaculada; Fernández-Tardón, Guillermo; Alguacil, Juan; Salas, Dolores; Marcos-Gragera, Rafael; Chirlaque, María Dolores; Aragonés, Nuria; Castaño-Vinyals, Gemma; Pollán Santamaría, Marina Anunciación; Kogevinas, Manolis; Llorca, Javier
2019